An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...

This treatment is given when TB is either resistant to rifampicin, a critical first-line drug, or rifampicin and isoniazid, another first-line drug combination. These resistant strains are ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

Many European countries are off track to meet official goals on HIV, TB, hepatitis, and STIs, a new report shows.

Malawi on April 17 declared an mpox outbreak after detecting its first three confirmed cases, the World Health Organization ...

Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that causes the disease, Mycobacterium tuberculosis, is deadly in part because of ...

Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that ...

March 24, 2025, was set aside by the World Health Organisation as World Tuberculosis Day to commemorate the day in 1882 when one of the true giants of early medicine, Dr Robert Koch, announced his ...

The Sustainable Development Goals (SDGs), adopted by the United Nations in 2015, offer a shared global vision for a more ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...